Devyser Diagnostics AB (FRA:OL0) Asset Turnover: 0.13 (As of Mar. 2026)


FRA:OL0 Devyser Diagnostics AB FRA:OL0
79 GF Score
Price €7.49
GF Value €13.58
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Devyser Diagnostics AB Asset Turnover?

Devyser Diagnostics AB FRA:OL0 -2.60% 79 Asset Turnover is 0.13 as of Mar. 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 79/100 and a GF Value™ of €13.58 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Devyser Diagnostics AB's Revenue for the three months ended in Mar. 2026 was €5.74 Mil. Devyser Diagnostics AB's Total Assets for the quarter that ended in Mar. 2026 was €43.40 Mil. Therefore, Devyser Diagnostics AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.13.

Asset Turnover is linked to ROE % through Du Pont Formula. Devyser Diagnostics AB's annualized ROE % for the quarter that ended in Mar. 2026 was 3.27%. It is also linked to ROA % through Du Pont Formula. Devyser Diagnostics AB's annualized ROA % for the quarter that ended in Mar. 2026 was 2.48%.


Devyser Diagnostics AB  (FRA:OL0) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Devyser Diagnostics AB's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=1.076/32.8925
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1.076 / 22.948)*(22.948 / 43.403)*(43.403/ 32.8925)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.69 %*0.5287*1.3195
=ROA %*Equity Multiplier
=2.48 %*1.3195
=3.27 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Devyser Diagnostics AB's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=1.076/43.403
=(Net Income / Revenue)*(Revenue / Total Assets)
=(1.076 / 22.948)*(22.948 / 43.403)
=Net Margin %*Asset Turnover
=4.69 %*0.5287
=2.48 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Devyser Diagnostics AB Asset Turnover Related Terms


Devyser Diagnostics AB Asset Turnover Historical Data

* Premium members only.

The historical data trend for Devyser Diagnostics AB's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB Asset Turnover Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only 0.35 0.26 0.33 0.44 0.55

Devyser Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.15 0.12 0.16 0.13

FRA:OL0 vs ABT, SYK, MDT: Asset Turnover Comparison

For the Medical Devices subindustry, Devyser Diagnostics AB's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Asset Turnover falls into.


FRA:OL0
79GF Score
Devyser Diagnostics AB FRA:OL0
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devyser Diagnostics AB Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Devyser Diagnostics AB's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=23.019/( (41.191+43.162)/ 2 )
=23.019/42.1765
=0.55

Devyser Diagnostics AB's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=5.737/( (43.162+43.644)/ 2 )
=5.737/43.403
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.13 mean?
Devyser Diagnostics AB (FRA:OL0) has a Asset Turnover of 0.13 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Devyser Diagnostics AB and its competitors.
Is Devyser Diagnostics AB's Asset Turnover too high?
Devyser Diagnostics AB's current Asset Turnover is 0.13. Overall, Devyser Diagnostics AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Asset Turnover compare to ABT and SYK?
Devyser Diagnostics AB's Asset Turnover of 0.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Devyser Diagnostics AB and its competitors. Devyser Diagnostics AB's current Asset Turnover is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.58, compared to a current price of €7.49 — trading 44.8% below its estimated fair value. The current Asset Turnover is 0.13. Devyser Diagnostics AB's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Asset Turnover is 0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of €7.49 is trading 44.8% below its estimated GF Value™ of €13.58. GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.

Key valuation signals for FRA:OL0:

  • Asset Turnover: 0.13
  • GF Value™: €13.58 vs. price of €7.49 (44.8% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Devyser Diagnostics AB Business Description

Other Exchanges DVYSR:Sweden
Address Branningevagen 12, Arsta, SWE, 120 54
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
79GF Score

Get the complete analysis for FRA:OL0

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.49
Price
€13.58
GF Value